Atlas Trials

Tafenoquine and ACTs (TADORE- Plus)

Clinical trial NCT07060794 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07060794
Sponsor
Menzies School of Health Research
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Vivax Malaria
Start date
2026-06-01
Primary completion
2028-06-01
Enrollment
507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.